학술논문

Dissecting the biological activity of different CDK4/6 inhibitors (CDK4/6i) in hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer (BC)
Document Type
Journal
Source
CANCER RESEARCH; MAR 1 2023, 83 5, 3p. Supplement: S
Subject
Language
English
ISSN
15387445